Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Direct links to NCBI, no account and no request form: the whole study as GSE61544_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 14 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA261431 and SRA study SRP047299. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 14 more — browse all 14 samples with per-sample file links →
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples
- GSE284666 SenCat: Redefining human cell senescence through multiomic profiling of multiple senescent cell types 190 samples
- GSE330029 Temporal changes in metabolism guide oligodendrocyte precursor cell dynamics in aging and multiple sclerosis [BulkRNAseq] 108 samples
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples
- GSE316922 Spatial biology reveals macrophage dysfunction in immunosuppressed non-melanoma skin cancer 36 samples
- GSE294272 Tumor-resident T cells and dendritic cells form an in situ archetype for immunotherapy response in melanoma [bulk RNA-seq] 29 samples
- GSE226176 Expression data of multiple myeloma patients at various stages of disease 23 samples
- GSE271107 Single-cell RNA sequencing of bone marrow aspirate samples from multiple myeloma and its precursor conditions 19 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.